Guillain barre syndrome

The South African Health Products Regulatory Authority (Sahpra) says a second death linked to the Covid-19 Johnson and Johnson vaccine has been confirmed.

"Covid-19 vaccines have consistently been shown to prevent severe forms of disease, hospitalisation and death. As previously communicated, GBS is a very rare but potentially severe neurological adverse event that is associated with the administration of various vaccines and other medicines and can also be triggered by some bacterial or viral infections, including SARS-CoV-2." The case was classified as a vaccine product-related event following investigations conducted and causality assessment. Semete-Makokotlela said investigations and causality assessments of all reported severe adverse events following immunisation with the Covid-19 vaccine, Johnson and Johnson vaccine and other Covid-19 vaccines are ongoing. The South African Health Products Regulatory Authority (Sahpra) says a second death linked to the Covid-19 Johnson and Johnson vaccine has been confirmed. - A second case of a rare syndrome linked to the Covid-19 vaccine has been confirmed.

A second fatal case of Guillain-Barré syndrome has been confirmed after vaccination with the Janssen jab for Covid-19, the SA Health Products Regulatory ...

The public are strongly advised not to delay Covid-19 vaccination if eligible in terms of the national vaccination programme.” The outcomes of these investigations and causality assessments will be shared with the public as soon as they are completed.” “Investigations and causality assessment of all reported severe AEFI with the Covid-19 Vaccine Janssen and other Covid-19 vaccines are ongoing.